3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
18
Prostatic Neoplasms
14
Lung Neoplasms
13
Colorectal Neoplasms
13
Lymphoma
5
Hematologic Neoplasms
5
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Hematopoietic and Lymphatic System Neoplasm
4
Anatomic Stage I Breast Cancer AJCC v8
4
Triple Negative Breast Neoplasms
3
Papillomavirus Infections
3
Pancreatic Neoplasms
3
Obesity-Related Malignant Neoplasm
3
Melanoma
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Skin Carcinoma
2
Neoplasms
2
Multiple Myeloma
2
Malignant Solid Neoplasm
2
Hematopoietic and Lymphoid System Neoplasm
2
Healthy Subject
2
Genital Neoplasms, Female
2
Endometrial Neoplasms
2
Breast Carcinoma In Situ
2
Advanced Malignant Solid Neoplasm
2
Vulvar Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
9
Cyclophosphamide
7
X-Rays
6
Temozolomide
6
Specimen Handling
6
Phantoms, Imaging
6
Biopsy
6
Nuclear Medicine Department, Hospital
5
Etoposide
5
Nivolumab
4
Bevacizumab
4
Radiation
3
Irinotecan
3
Automobiles
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
lutetium Lu 177 dotatate
2
larotrectinib
2
ivosidenib
2
etoposide phosphate
2
erdafitinib
2
ensartinib
2
abemaciclib
2
Watchful Waiting
2
Radiotherapy
2
ONC206
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ependymoma
×
Early Intervention, Educational
×
1 year
×
Clear all
No trials found.